171 related articles for article (PubMed ID: 30423417)
1. Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin.
Campaña-Seoane M; Pérez-Gago A; Vázquez G; Conde N; González P; Martinez A; Martínez X; García Varela L; Herranz M; Aguiar P; Fernández-Ferreiro A; Laguna R; Otero-Espinar FJ
Int J Pharm; 2019 Jan; 554():276-283. PubMed ID: 30423417
[TBL] [Abstract][Full Text] [Related]
2. Bioadhesive emulsions for control release of progesterone resistant to vaginal fluids clearance.
Campaña-Seoane M; Peleteiro A; Laguna R; Otero-Espinar FJ
Int J Pharm; 2014 Dec; 477(1-2):495-505. PubMed ID: 25445529
[TBL] [Abstract][Full Text] [Related]
3. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
[TBL] [Abstract][Full Text] [Related]
4. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
[TBL] [Abstract][Full Text] [Related]
5. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Abdelbary G
Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
[TBL] [Abstract][Full Text] [Related]
6. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
[TBL] [Abstract][Full Text] [Related]
7. Vaginal distribution and retention of a multiparticulate drug delivery system, assessed by gamma scintigraphy and magnetic resonance imaging.
Mehta S; Verstraelen H; Peremans K; Villeirs G; Vermeire S; De Vos F; Mehuys E; Remon JP; Vervaet C
Int J Pharm; 2012 Apr; 426(1-2):44-53. PubMed ID: 22265911
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
9. W/O/W multiple emulsions containing nitroimidazole derivates for vaginal delivery.
Ozer O; Ozyazici M; Tedajo M; Taner MS; Köseoglu K
Drug Deliv; 2007 Mar; 14(3):139-45. PubMed ID: 17454033
[TBL] [Abstract][Full Text] [Related]
10. Vaginal mucoadhesive drug delivery systems.
de Araújo Pereira RR; Bruschi ML
Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
[TBL] [Abstract][Full Text] [Related]
11. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
Hombach J; Palmberger TF; Bernkop-Schnürch A
J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Delivery of Benzydamine Hydrochloride through Liposomes Dispersed in Mucoadhesive Gels.
Tuğcu-Demiröz F
Chem Pharm Bull (Tokyo); 2017 Jul; 65(7):660-667. PubMed ID: 28442642
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive microspheres: a promising tool in drug delivery.
Patil SB; Sawant KK
Curr Drug Deliv; 2008 Oct; 5(4):312-8. PubMed ID: 18855602
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
15. The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system.
Yoo JW; Dharmala K; Lee CH
Int J Pharm; 2006 Feb; 309(1-2):139-45. PubMed ID: 16376036
[TBL] [Abstract][Full Text] [Related]
16. Advanced topical drug delivery system for the management of vaginal candidiasis.
Johal HS; Garg T; Rath G; Goyal AK
Drug Deliv; 2016; 23(2):550-63. PubMed ID: 24959937
[TBL] [Abstract][Full Text] [Related]
17. Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating properties.
Zaichik S; Steinbring C; Menzel C; Knabl L; Orth-Höller D; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2018 Aug; 547(1-2):282-290. PubMed ID: 29883790
[TBL] [Abstract][Full Text] [Related]
18. Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
Notario-Pérez F; Martín-Illana A; Cazorla-Luna R; Ruiz-Caro R; Bedoya LM; Tamayo A; Rubio J; Veiga MD
Mar Drugs; 2017 Feb; 15(2):. PubMed ID: 28230790
[TBL] [Abstract][Full Text] [Related]
19. Dual effect biodegradable ciprofloxacin loaded implantable matrices for osteomyelitis: controlled release and osteointegration.
Hanafy AF; Ali HSM; El Achy SN; Habib EE
Drug Dev Ind Pharm; 2018 Jun; 44(6):1023-1033. PubMed ID: 29484904
[TBL] [Abstract][Full Text] [Related]
20. Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.
Notario-Pérez F; Martín-Illana A; Cazorla-Luna R; Ruiz-Caro R; Peña J; Veiga MD
Eur J Pharm Sci; 2018 May; 117():204-215. PubMed ID: 29477644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
